Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.28576 | 11 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.28504 | 11 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.29711 | 12 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.45382 | 21 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.38383 | 18 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.32291 | 11 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.28136 | 10 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.27515 | 12 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.27011 | 12 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.28138 | 12 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.27671 | 12 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.27319 | 12 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.28044 | 11 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.28454 | 12 |